Im Oktober 2010 gab Boehringer bekannt, die Entwicklung von Flibanserin vorerst einzustellen. ###>==Withdrawal==On October 8, 2010, Boehringer Ingelheim announced that it would discontinue its development of flibanserin in light of the FDA advisory panel's recommendation.